biote (NASDAQ:BTMD – Get Free Report) and Rockwell Medical (NASDAQ:RMTI – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends.
Valuation & Earnings
This table compares biote and Rockwell Medical”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| biote | $192.22 million | 0.28 | $27.05 million | $0.75 | 1.80 |
| Rockwell Medical | $69.26 million | 0.51 | -$5.31 million | ($0.15) | -5.95 |
Analyst Ratings
This is a breakdown of recent ratings and price targets for biote and Rockwell Medical, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| biote | 1 | 1 | 1 | 0 | 2.00 |
| Rockwell Medical | 1 | 0 | 1 | 0 | 2.00 |
biote presently has a consensus target price of $3.00, indicating a potential upside of 122.22%. Rockwell Medical has a consensus target price of $2.00, indicating a potential upside of 123.91%. Given Rockwell Medical’s higher possible upside, analysts plainly believe Rockwell Medical is more favorable than biote.
Profitability
This table compares biote and Rockwell Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| biote | 14.07% | -23.41% | 14.63% |
| Rockwell Medical | -7.67% | -15.64% | -9.61% |
Institutional & Insider Ownership
21.7% of biote shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 24.0% of biote shares are owned by company insiders. Comparatively, 1.9% of Rockwell Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Risk & Volatility
biote has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500. Comparatively, Rockwell Medical has a beta of 1.71, indicating that its stock price is 71% more volatile than the S&P 500.
Summary
biote beats Rockwell Medical on 7 of the 12 factors compared between the two stocks.
About biote
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
About Rockwell Medical
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Receive News & Ratings for biote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biote and related companies with MarketBeat.com's FREE daily email newsletter.
